Literature DB >> 3212157

Tardive and withdrawal dyskinesia in autistic children: a prospective study.

M Campbell, P Adams, R Perry, E K Spencer, J E Overall.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3212157

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  13 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

2.  Galantamine may be effective in treating autistic disorder.

Authors:  Helmut Niederhofer; W Staffen; A Mair
Journal:  BMJ       Date:  2002-12-14

Review 3.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

4.  Brief report: a double-blind study of naltrexone in infantile autism.

Authors:  M Leboyer; M P Bouvard; J M Launay; F Tabuteau; D Waller; M Dugas; B Kerdelhue; P Lensing; J Panksepp
Journal:  J Autism Dev Disord       Date:  1992-06

Review 5.  Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.

Authors:  N Carrey; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  1998-11       Impact factor: 6.186

6.  Efficacy of duloxetine and agomelatine does not exceed that of other antidepressants in patients with autistic disorder: preliminary results in 3 patients.

Authors:  Helmut Niederhofer
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 7.  Understanding developmental pharmacodynamics: importance for drug development and clinical practice.

Authors:  Hussain Mulla
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

8.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

Review 9.  Medication treatment in subjects with autistic spectrum disorders.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

10.  Use of methylphenidate in the treatment of children with autistic disorder.

Authors:  H Quintana; B Birmaher; D Stedge; S Lennon; J Freed; J Bridge; L Greenhill
Journal:  J Autism Dev Disord       Date:  1995-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.